Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]
{"title":"Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]","authors":"Ekaterina V. Yudina","doi":"10.26442/18151434.2023.4.202545","DOIUrl":null,"url":null,"abstract":"This publication is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review: Zachou G, El-Khouly F, Dilley J. Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment. Cochrane Database Syst Rev. 2023;8(8):CD006119. DOI: 10.1002/14651858.CD006119.pub4","PeriodicalId":16401,"journal":{"name":"Journal of Modern Oncology","volume":"13 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Modern Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26442/18151434.2023.4.202545","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
This publication is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review: Zachou G, El-Khouly F, Dilley J. Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment. Cochrane Database Syst Rev. 2023;8(8):CD006119. DOI: 10.1002/14651858.CD006119.pub4
本出版物是 Cochrane 系统综述的通俗语言摘要 (PLS) 的俄文译本:Zachou G, El-Khouly F, Dilley J. Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment.Cochrane Database Syst Rev. 2023; 8(8):CD006119.DOI: 10.1002/14651858.CD006119.pub4